LT5524B - Farmacinė kompozicija, kurios pagrindą sudaro atvirkštinės transkriptazės inhibitorius ir meldoniumas - Google Patents
Farmacinė kompozicija, kurios pagrindą sudaro atvirkštinės transkriptazės inhibitorius ir meldoniumas Download PDFInfo
- Publication number
- LT5524B LT5524B LT2008003A LT2008003A LT5524B LT 5524 B LT5524 B LT 5524B LT 2008003 A LT2008003 A LT 2008003A LT 2008003 A LT2008003 A LT 2008003A LT 5524 B LT5524 B LT 5524B
- Authority
- LT
- Lithuania
- Prior art keywords
- meldonium
- pharmaceutical composition
- lamivudine
- reverse transcriptase
- stavudine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LVP-05-95A LV13544B (en) | 2005-08-15 | 2005-08-15 | Pharmaceutical composition containing reverse transcriptase inhibitor and meldonium |
Publications (2)
Publication Number | Publication Date |
---|---|
LT2008003A LT2008003A (en) | 2008-07-25 |
LT5524B true LT5524B (lt) | 2008-10-27 |
Family
ID=37442067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LT2008003A LT5524B (lt) | 2005-08-15 | 2008-01-18 | Farmacinė kompozicija, kurios pagrindą sudaro atvirkštinės transkriptazės inhibitorius ir meldoniumas |
Country Status (17)
Country | Link |
---|---|
US (1) | US7700576B2 (et) |
EP (1) | EP1933823B1 (et) |
JP (1) | JP5027809B2 (et) |
CN (1) | CN101252925B (et) |
AR (1) | AR066995A1 (et) |
AT (1) | ATE493123T1 (et) |
DE (1) | DE602006019293D1 (et) |
EE (1) | EE05529B1 (et) |
ES (1) | ES2361185T3 (et) |
HN (1) | HN2006029085A (et) |
LT (1) | LT5524B (et) |
LV (1) | LV13544B (et) |
PE (1) | PE20070233A1 (et) |
SV (1) | SV2007002655A (et) |
UA (1) | UA90162C2 (et) |
UY (1) | UY29751A1 (et) |
WO (1) | WO2007021164A1 (et) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GEP20146015B (en) * | 2009-06-25 | 2014-01-27 | Tetra Sia | Novel acetylsalicylic acid salts |
LV14848B (lv) * | 2012-10-25 | 2015-06-20 | Latvijas Organiskās Sintēzes Institūts | Farmaceitiska kompozīcija trimetilamīna-N-oksīda līmeņa pazemināšanai |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4481218A (en) | 1978-11-27 | 1984-11-06 | Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr | 3-(2,2,2-Trimethylhydrazinium)propionate and method for the preparation and use thereof |
US4724232A (en) | 1985-03-16 | 1988-02-09 | Burroughs Wellcome Co. | Treatment of human viral infections |
WO1991017159A1 (en) | 1990-05-02 | 1991-11-14 | Iaf Biochem International Inc. | 1,3-oxathiolane nucleoside analogues |
US5130421A (en) | 1988-03-24 | 1992-07-14 | Bristol-Myers Company | Production of 2',3'-dideoxy-2',3'-didehydronucleosides |
EP0560275A1 (en) | 1992-03-11 | 1993-09-15 | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. | Use of L-carnitine for treating carnitine-depleted HIV-seropositive patients |
-
2005
- 2005-08-15 LV LVP-05-95A patent/LV13544B/lv unknown
-
2006
- 2006-08-08 DE DE602006019293T patent/DE602006019293D1/de active Active
- 2006-08-08 EP EP06783790A patent/EP1933823B1/en active Active
- 2006-08-08 US US11/990,285 patent/US7700576B2/en not_active Expired - Fee Related
- 2006-08-08 WO PCT/LV2006/000005 patent/WO2007021164A1/en active Application Filing
- 2006-08-08 UA UAA200803268A patent/UA90162C2/ru unknown
- 2006-08-08 CN CN2006800298828A patent/CN101252925B/zh not_active Expired - Fee Related
- 2006-08-08 JP JP2008526897A patent/JP5027809B2/ja not_active Expired - Fee Related
- 2006-08-08 EE EEP200800014A patent/EE05529B1/et not_active IP Right Cessation
- 2006-08-08 ES ES06783790T patent/ES2361185T3/es active Active
- 2006-08-08 AT AT06783790T patent/ATE493123T1/de not_active IP Right Cessation
- 2006-08-11 AR ARP060103527A patent/AR066995A1/es unknown
- 2006-08-14 UY UY29751A patent/UY29751A1/es not_active Application Discontinuation
- 2006-08-14 PE PE2006000983A patent/PE20070233A1/es not_active Application Discontinuation
- 2006-08-15 SV SV2006002655A patent/SV2007002655A/es not_active Application Discontinuation
- 2006-08-15 HN HN2006029085A patent/HN2006029085A/es unknown
-
2008
- 2008-01-18 LT LT2008003A patent/LT5524B/lt not_active IP Right Cessation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4481218A (en) | 1978-11-27 | 1984-11-06 | Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr | 3-(2,2,2-Trimethylhydrazinium)propionate and method for the preparation and use thereof |
US4724232A (en) | 1985-03-16 | 1988-02-09 | Burroughs Wellcome Co. | Treatment of human viral infections |
US5130421A (en) | 1988-03-24 | 1992-07-14 | Bristol-Myers Company | Production of 2',3'-dideoxy-2',3'-didehydronucleosides |
WO1991017159A1 (en) | 1990-05-02 | 1991-11-14 | Iaf Biochem International Inc. | 1,3-oxathiolane nucleoside analogues |
EP0560275A1 (en) | 1992-03-11 | 1993-09-15 | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. | Use of L-carnitine for treating carnitine-depleted HIV-seropositive patients |
Non-Patent Citations (2)
Title |
---|
BROCKLEHURST P, VOLMINK J.: "Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.", COCHRANE DATABASE SYST REV., 2002, pages 003510 |
LEWIS W. ET AL.: "Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria", J. CLIN. INVEST., 1992, pages 1354 - 1360, XP002963913, DOI: doi:10.1172/JCI115722 |
Also Published As
Publication number | Publication date |
---|---|
AR066995A1 (es) | 2009-09-30 |
EE05529B1 (et) | 2012-04-16 |
UA90162C2 (ru) | 2010-04-12 |
JP2009504731A (ja) | 2009-02-05 |
PE20070233A1 (es) | 2007-06-08 |
JP5027809B2 (ja) | 2012-09-19 |
WO2007021164A1 (en) | 2007-02-22 |
EP1933823B1 (en) | 2010-12-29 |
ATE493123T1 (de) | 2011-01-15 |
CN101252925B (zh) | 2012-04-25 |
ES2361185T3 (es) | 2011-06-14 |
EE200800014A (et) | 2008-06-16 |
HN2006029085A (es) | 2007-11-16 |
LV13544B (en) | 2007-05-20 |
DE602006019293D1 (de) | 2011-02-10 |
CN101252925A (zh) | 2008-08-27 |
LT2008003A (en) | 2008-07-25 |
SV2007002655A (es) | 2007-04-12 |
US7700576B2 (en) | 2010-04-20 |
UY29751A1 (es) | 2007-03-30 |
US20090137522A1 (en) | 2009-05-28 |
EP1933823A1 (en) | 2008-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20020169140A1 (en) | Combination therapy for reduction of toxicity of chemotherapeutic agents | |
US5719132A (en) | Compositions and methods of treating HIV with d4T, 5-fluorouracil/tegafur, and uracil | |
CN107898790A (zh) | 用于治疗或预防逆转录病毒和其它病毒感染的抗病毒jak抑制剂 | |
KR20080091767A (ko) | (테노포비어 및 라미뷰딘과 같은) 뉴클레오티드 역전사효소억제제 및 뉴클레오시드 역전사효소 억제제를 투여 단위의상이한 부분에 포함하는 약제학적 조합물 | |
JP2004517864A (ja) | ウイルスの複製を阻害するためのアデノシンa3受容体アゴニストの使用 | |
US10369166B2 (en) | Pharmaceutical compositions for treating ebola virus disease | |
EP1272897B1 (en) | Adenosine a2a receptor antagonists for treating and preventing hepatic fibrosis, cirrhosis and fatty liver | |
Nelson et al. | Emtricitabine (FTC) for the treatment of HIV infection | |
AU2001238124A1 (en) | Adenosine a2a receptor antagonists for treating and preventing hepatic fibrosis,cirrhosis and fatty liver | |
Margot et al. | In vitro combination studies of tenofovir and other nucleoside analogues with ribavirin against HIV-1 | |
LT5524B (lt) | Farmacinė kompozicija, kurios pagrindą sudaro atvirkštinės transkriptazės inhibitorius ir meldoniumas | |
WO2021205437A1 (en) | Pharmaceutical compositions for treating corona virus disease | |
EP0839033B1 (en) | Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral | |
CA2344172A1 (en) | Antiviral combinations | |
Lemberg et al. | Tolerabilities of antiretrovirals in paediatric HIV infection | |
TWI405569B (zh) | 色素沉著症治療用一日二次服用型口服藥製劑 | |
TWI324927B (en) | Pharmaceutical composition on basis of reverse transcriptase inhibitor and meldonium | |
MXPA03005382A (es) | Terapia combinada de dapd con un inhibidor de inosino monofosfato dehidrogenasa. | |
US20140065246A1 (en) | Intracellular calcium modulation for cancer treatment | |
US7745455B2 (en) | Zalcitabine (ddC) boosted lamivudine (3TC) compositions for antiretroviral therapy | |
Blonk | Clinical pharmacology of the HIV integrase inhibitor raltegravir: drug-drug interactions and pharmacokinetics | |
RU106840U1 (ru) | Диспергируемая в воде лекарственная таблетка противотуберкулезного действия | |
KR20230044481A (ko) | 감기약 및 항바이러스제 | |
CA2284483A1 (en) | Mixtures of at least two reverse transcriptase inhibitors and hydroxycarbamide, in particular for inhibiting retroviral spread |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM9A | Lapsed patents |
Effective date: 20140808 |